Search Results - "Kim, Min Gun"
-
1
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
Published in Cancer medicine (Malden, MA) (01-01-2023)“…Grade 3/4 anaemia, which is mainly induced by carboplatin, frequently occurs in patients treated with neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab…”
Get full text
Journal Article -
2
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Published in International journal of cancer (01-09-2019)“…Deregulation of the cyclin D‐CDK4/6‐INK4‐RB pathway leading to uncontrolled cell proliferation, is frequently observed in breast cancer. Currently, three…”
Get full text
Journal Article -
3
Prevalence and associated factors of psychological distress among Korean cancer patients
Published in General hospital psychiatry (01-05-2011)“…Abstract Objectives This study primarily aimed to investigate the prevalence and associated factors of psychological distress among Korean cancer patients. Its…”
Get full text
Journal Article -
4
Genomic landscape of extraordinary responses in metastatic breast cancer
Published in Communications biology (09-04-2021)“…Extreme responders to anticancer therapy are rare among advanced breast cancer patients. Researchers, however, have yet to investigate treatment responses…”
Get full text
Journal Article -
5
A Temperature-Independent Transmitter IC for 5.8-GHz DSRC Applications
Published in IEEE transactions on circuits and systems. I, Regular papers (01-07-2008)“…This paper describes a transmitter integrated circuit (IC) for 5.8-GHz dedicated short-range communication applications. It consists of a baseband…”
Get full text
Journal Article -
6
Prevalence and prognostic implications of psychological distress in patients with gastric cancer
Published in BMC cancer (20-04-2017)“…The aim of this study was to investigate the prevalence and prognostic significance of psychological distress in gastric cancer patients. The study population…”
Get full text
Journal Article -
7
Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
Published in Investigational new drugs (01-10-2021)“…Summary TAS-117 is a potent and selective allosteric pan-v-akt murine thymoma viral oncogene homolog (Akt) inhibitor. We conducted a single-arm single-center…”
Get full text
Journal Article -
8
Three-dimensional symmetry and parallelism of the skeletal and soft-tissue poria in patients with facial asymmetry
Published in Korean journal of orthodontics (2012) (01-03-2014)“…The purpose of this study was to examine the symmetry and parallelism of the skeletal and soft-tissue poria by three-dimensional (3D) computed tomographic (CT)…”
Get full text
Journal Article -
9
Anti-inflammatory effects of immature Citrus unshiu fruit extracts via suppression of NF-κB and MAPK signal pathways in LPS-induced RAW264.7 macrophage cells
Published in Food science and biotechnology (01-03-2024)“…This study examined the anti-inflammatory effects of 70% ethanol crude extract of immature Citrus unshiu fruits (ICE) and its solvent fractions in…”
Get full text
Journal Article -
10
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
Published in Breast cancer research : BCR (12-01-2023)“…Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have been established as a standard treatment for hormone receptor (HR)-positive, human epidermal growth…”
Get full text
Journal Article -
11
Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study
Published in Supportive care in cancer (01-03-2020)“…Purpose Cancer treatment may relate to appetite reduction and malnutrition. We investigated taste alterations and dish-type preferences during chemo- and/or…”
Get full text
Journal Article -
12
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation
Published in Experimental & molecular medicine (01-04-2024)“…Transcriptional programs governed by YAP play key roles in conferring resistance to various molecular-targeted anticancer agents. Strategies aimed at…”
Get full text
Journal Article -
13
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
Published in Breast cancer research and treatment (01-02-2020)“…Purpose An antibody–drug conjugate targeting HER2, DS8201, has shown clinical activity against breast cancer with low-level HER2 expression. We aimed to…”
Get full text
Journal Article -
14
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
Published in Breast (Edinburgh) (01-04-2022)“…Palbociclib plus endocrine therapy (ET) demonstrated significant progression-free survival (PFS) benefit in Young Pearl, a randomized phase ll trial comparing…”
Get full text
Journal Article -
15
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA
Published in Nature communications (10-04-2023)“…Multi-cancer early detection remains a key challenge in cell-free DNA (cfDNA)-based liquid biopsy. Here, we perform cfDNA whole-genome sequencing to generate…”
Get full text
Journal Article -
16
Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts
Published in International journal of molecular sciences (15-08-2022)“…Liquid biopsy has been emerging for early screening and treatment monitoring at each cancer stage. However, the current blood-based diagnostic tools in breast…”
Get full text
Journal Article -
17
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
Published in Breast cancer research and treatment (01-08-2020)“…Purpose Neutropenia is the most common toxicity of CDK4/6 inhibitors, causing frequent dose interruptions. However, CDK4/6 inhibitor-induced neutropenia shows…”
Get full text
Journal Article -
18
Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers
Published in BMC medicine (27-09-2024)“…Breast cancer (BC) is a complex disease with profound genomic aberrations. However, the underlying molecular disparity influenced by age and ethnicity remains…”
Get full text
Journal Article -
19
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
Published in Breast cancer research and treatment (01-09-2020)“…In the original publication of the article, under the Results section, subheading “Patient survival”, the second sentence that reads as “The 6-month PFS was…”
Get full text
Journal Article -
20
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
Published in Frontiers in oncology (04-06-2021)“…The trastuzumab biosimilar CT-P6 has demonstrated equivalent efficacy and comparable safety to reference trastuzumab (RTZ) in clinical trials of human…”
Get full text
Journal Article